Palvella Therapeutics, Inc.

PVLA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$83,602$7,350$16,053$117,764
Short-Term Investments$0$0$0$0
Receivables$2,336$0$0$3,313
Inventory$0$0$0$0
Other Curr. Assets$2,296$198$471$6,548
Total Curr. Assets$88,234$7,548$16,524$127,625
Property Plant & Equip (Net)$0$0$0$23,031
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$2,904
Total NC Assets$0$0$0$25,935
Other Assets$0$0$0$0
Total Assets$88,234$7,548$16,524$153,560
Liabilities
Payables$4,586$936$3,181$8,609
Short-Term Debt$0$0$0$1,049
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$25,116
Other Curr. Liab.$7,452$1,424$2,601$15,787
Total Curr. Liab.$12,038$2,360$5,782$50,561
LT Debt$0$0$0$13,841
Deferred Rev, NC$0$0$0$38,403
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$13,589$9,068$33,916$0
Total NC Liab.$13,589$9,068$33,916$52,244
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$13,841
Total Liabilities$25,627$11,428$39,698$102,805
Equity
Pref Stock$0$70,603$70,603$0
Common Stock$11$0$0$72
Retained Earnings-$93,735-$76,301-$94,992-$257,144
AOCI$3$0$0$829
Other Equity$156,328$1,818$1,215$306,998
Total Equity$62,607-$3,880-$23,174$50,755
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$88,234$7,548$16,524$153,560
Net Debt-$83,602-$7,350-$16,053-$102,874